FI47985C - Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi

Info

Publication number
FI47985C
FI47985C FI701016A FI101670A FI47985C FI 47985 C FI47985 C FI 47985C FI 701016 A FI701016 A FI 701016A FI 101670 A FI101670 A FI 101670A FI 47985 C FI47985 C FI 47985C
Authority
FI
Finland
Prior art keywords
17alpha
preparation
therapeutically useful
propadienyl
steroids
Prior art date
Application number
FI701016A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI47985B (de
Inventor
Edwards
Original Assignee
Syntex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Corp filed Critical Syntex Corp
Application granted granted Critical
Publication of FI47985B publication Critical patent/FI47985B/fi
Publication of FI47985C publication Critical patent/FI47985C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
FI701016A 1969-04-18 1970-04-13 Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi FI47985C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81756369A 1969-04-18 1969-04-18
US87752169A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
FI47985B FI47985B (de) 1974-01-31
FI47985C true FI47985C (fi) 1974-05-10

Family

ID=27124181

Family Applications (1)

Application Number Title Priority Date Filing Date
FI701016A FI47985C (fi) 1969-04-18 1970-04-13 Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi

Country Status (15)

Country Link
JP (1) JPS4916857B1 (de)
AT (1) AT322120B (de)
BE (1) BE749067A (de)
CA (1) CA919167A (de)
CH (1) CH540894A (de)
DE (1) DE2018055B2 (de)
DK (1) DK133813C (de)
ES (1) ES378764A1 (de)
FI (1) FI47985C (de)
FR (1) FR2051496B1 (de)
GB (2) GB1310612A (de)
IL (2) IL34228A (de)
NL (1) NL7005604A (de)
NO (1) NO134553C (de)
SE (1) SE355802B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH571537A5 (de) * 1970-04-24 1976-01-15 Sandoz Ag
GB1348186A (en) * 1970-04-24 1974-03-13 Sandoz Ltd 17alpha-propadienyl steroids

Also Published As

Publication number Publication date
IL44105A0 (en) 1974-05-16
IL34228A (en) 1975-04-25
AT322120B (de) 1975-05-12
BE749067A (fr) 1970-10-01
JPS4916857B1 (de) 1974-04-25
DE2018055B2 (de) 1976-12-23
GB1310612A (en) 1973-03-21
NO134553B (de) 1976-07-26
FR2051496A1 (de) 1971-04-09
ES378764A1 (es) 1973-02-01
IL34228A0 (en) 1970-06-17
CH540894A (de) 1973-08-31
CA919167A (en) 1973-01-16
DE2018055A1 (de) 1970-10-22
NL7005604A (de) 1970-10-20
GB1310611A (en) 1973-03-21
FI47985B (de) 1974-01-31
DK133813B (da) 1976-07-26
SE355802B (de) 1973-05-07
DK133813C (da) 1976-12-13
NO134553C (de) 1976-11-03
FR2051496B1 (de) 1973-03-16

Similar Documents

Publication Publication Date Title
RO58861A2 (ro) Procedeu de preparare a unor beta-aril-2-aminoalcoxistireni
CH453351A (fr) Procédé de préparation de stéroïdes
IL33369A0 (en) Process for the preparation of steroids
FI46373C (fi) Menetelmä fenyyliaminopropaanin uusien terapeuttisesti käyttökelpoiste n johdannaisten valmistamiseksi.
FI50418C (fi) Menetelmä terapeuttisesti käytettävien tiokarbamidihappojohdannaisten valmistamiseksi
FI50410C (fi) Menetelmä tulehdusta estävien substituoitujen aminopyriinien valmistam iseksi
IL35823A0 (en) Process for the preparation of 16beta-methyl-9alpha-fluoro-steroids of the pregnane series
CH507227A (fr) Procédé de préparation de stéroïdes
PH9298A (en) Process for the manufacture of pregnane compounds
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI47985C (fi) Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi
FI47883C (fi) Menetelmä terapeuttisesti käytettävien 17alfa-propadienyyli-steroidien valmistamiseksi
CH491895A (fr) Procédé de préparation de stéroïdes
FI50521C (fi) Menetelmä terapeuttisesti käytettävien d-2-(6-substituoitu-2-naftyyli) -propanaalien valmistamiseksi
BR6912536D0 (pt) Processo para a preparacao de um glicosil esteroide
FI46952C (fi) Menetelmä 6alfa-fluori-9alfa,11beta,21-trihalogeeni-1,4-pregnadieeni-3 ,20-dioni-johdannaisten valmistamiseksi
IL37238A (en) Process for the manufacture of a pyroglutamylpeptide
FI46966C (fi) Menetelmä terapeuttisesti käytettävien 1,3-dihydro-3-hydroksi-1,4-bent sodiatsepiini-2-onien valmistamiseksi
BR6915400D0 (pt) Processo para a preparacao de 16-metil-esteroides
SE381870B (sv) Forfarande for framstellning av vissa angivna terapeutiskt anvendbara butyramidiner
IL35791A0 (en) Process for the preparation of steroids
FI49605C (fi) Menetelmä terapeuttisesti käytettävien tetrahydroisokinoliinijohdannai sten valmistamiseksi
CH506509A (fr) Procédé de préparation de stéroïdes
CH487878A (fr) Procédé de préparation de stéroïdes
FI48076C (fi) Menetelmä 14-anhydrobufaliinin valmistamiseksi